Does fish-oil capsule EPA delivery vary by label, form, food, oxidation, and adherence?

Fish-oil capsules are not interchangeable sources of systemic EPA exposure: the stated dose, formulation, administration conditions, product integrity, and actual use all influence how much intact EPA reaches the body over time.

Clinical and exposure evidence

• Labelled EPA content sets the intended dose, and dose-ranging randomized evidence found 300–1,800 mg/day EPA+DHA increased erythrocyte EPA+DHA by approximately 44%–121% versus placebo over about five months. Yet label claims are not assurance of measured content: one survey found EPA values from 2.8% above to 11.1% below declared amounts, and another found mean EPA+DHA content of 68% of label.
• Chemical form changes absorption. Re-esterified triglyceride had greater relative EPA+DHA bioavailability than ethyl ester in controlled research; monoglyceride EPA produced roughly twice the plasma EPA AUC of ethyl ester or triglyceride in a crossover study. Ethyl-ester versus triglyceride differences are meal-dependent rather than uniform.
• Fat-containing meals are particularly consequential for ethyl esters. High-fat meals increased combined EPA+DHA exposure about 5.4-fold versus fasting/low-fat administration in one controlled comparison; FDA-reviewed studies reported up to 20-fold higher peak concentrations and 60–80-fold higher overall exposure versus fasting.

Mechanisms and practical considerations

• Dietary fat promotes bile secretion, carboxyl-ester lipase activity, micellar solubilization, uptake, and chylomicron transport—explaining the pronounced food effect for ethyl esters.
• EPA’s five double bonds are oxidation-prone; oxidation converts intact EPA to peroxides and secondary products. However, a 7-week trial (peroxide value 18 mEq/kg) found similar plasma EPA increases with oxidized and fresh oil.
• Missed doses directly reduce cumulative EPA intake. Plasma EPA reflects relatively recent intake, whereas erythrocyte EPA and the omega-3 index reflect sustained exposure over roughly 120 days.

Bottom line

• The claim is supported: delivered EPA varies materially with dose label, formulation, meal fat, product oxidation, and—most importantly in practice—consistent adherence.